Related Experiment Videos
Intracoronary platelet aggregation: pattern of deposition after ischemia, cardioplegia, and reperfusion
Insights
Transient ischemia during heart bypass activates coronary platelets. This platelet aggregation persists through cardioplegia and increases during reperfusion, suggesting a role in myocardial injury and the need for antiplatelet therapy.
Area of Science:
- Cardiovascular Science
- Hematology
- Surgical Research
Background:
- Platelet deposition in coronary microvasculature during acute myocardial ischemia, cardioplegia, and reperfusion on heart bypass requires definition.
- Understanding platelet behavior is crucial for mitigating ischemia-reperfusion injury.
Purpose of the Study:
- To investigate the temporal relationship of platelet deposition in the coronary microvasculature.
- To analyze platelet activation and aggregation during transient ischemia, cardioplegic arrest, and reperfusion in a heart bypass model.
Main Methods:
- Utilized radioactively tagged platelets in 22 canine hearts undergoing serial biopsies.
- Compared platelet deposition in hearts subjected to bypass, cardioplegic arrest, and reperfusion against nonischemic controls.
Main Results:
- Transient ischemia during bypass preparation induced significant myocardial platelet aggregation (P = 0.005).
- Potassium cardioplegia did not fully reverse ischemia-induced platelet deposition (P = 0.04).
- Reperfusion following cardioplegic arrest led to a profound and sustained increase in platelet radioactivity (P = 0.0101, P = 0.0369).
Conclusions:
- Transient ischemia during heart bypass activates intracoronary platelets.
- Ischemia-activated platelet aggregation persists despite cardioplegia and exacerbates during reperfusion.
- This pattern suggests a mechanism for progressive reperfusion injury, supporting antiplatelet strategies for coronary microvascular protection.
Abstract:
Platelet deposition in the coronary microvasculature has not been completely defined in the temporal relationship to acute myocardial ischemia, the application of crystalloid cardioplegia, and during reperfusion on heart bypass. Twenty-two canine hearts were serially biopsied for the analysis of radioactively tagged platelets. Eleven hearts underwent an isolated heart support preparation with seven followed by potassium cardioplegic arrest and reperfusion while the remaining 4 were maintained on continuous bypass. All 11 hearts undergoing bypass experienced transient (less than 90 sec) ischemia during bypass preparation and produced platelet aggregation in the myocardium (51.12 +/- 24.0 as compared to nonischemic control group 12.3 +/- 4.7; P = 0.005). Potassium cardioplegia did not completely wash out these platelets to the nonischemic control levels (27.8 +/- 14.9; P = 0.04). With the onset of reperfusion after 1 hr of cardioplegic arrest, platelet radioactivity profoundly increased (133.3 +/- 72.8; P = 0.0101) and remained high throughout the hour of reperfusion (324.7 +/- 269.3; P = 0.0369). In summary, intracoronary platelets are activated after transient ischemic episodes during initiation of heart bypass. These ischemia-activated platelet aggregations persist despite the application of cardioplegia during the arrest period. This deposition, in turn, allowed an ongoing pattern of platelet aggregation during the early and subsequent reperfusion. This pattern of ischemia-activated platelet aggregations probably accounts for the progressive reperfusion injury and support of an antiplatelet treatment for coronary microvasculature protection.